Cancer Progress

30+ Years of Scientific Discussions and Connections

Cancer Progress was started in 1989 with the goal of facilitating discussions of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives. A predecessor company of Lumanity, Defined Health, took over the event in 2011. Cancer Progress has historically featured two to three days of provocative, informative panel discussions with pivotal topics, frank discussions, vigorous debate, opportunities for audience questions and comments, and a partnering platform to enable meaningful connections and meetings with innovators, developers, and investors.

Cancer Progress: April 9, 2026

We are thrilled to announce that Cancer Progress is returning in 2026, as an in-person event in the heart of New York City!

This streamlined, one-day conference promises a focused and impactful experience. Attendees can expect unparalleled insights, in-depth issue coverage, and exceptional networking opportunities. The conference’s enduring success and value are driven by the expertise and reputation of its distinguished speaking faculty.

In addition to delivering high-quality content and connections, this year’s Cancer Progress will make a lasting impact beyond the conference walls. All net proceeds from ticket sales and event sponsorships will be directed to support cancer research through a dedicated charitable partner(s). Our selected organization — to be announced soon — will be a recognized leader in advancing breakthroughs and improving outcomes for patients worldwide.

We hope you join us for this dynamic gathering of experts for a thought-provoking exploration of the possibilities and challenges inherent in shaping the future of oncology.

Stay Tuned! More information coming soon.

As I like to say, Cancer Progress is THE BEST non-academic cancer conference out there. Again proving your staggering insight!

Michael G. King Jr. Entrepreneur in Residence, Fortress Biotech Inc.

1 / 4

When we hear all the negatives from the experts on the cell therapies and COVID - let's think of Richard Feynman: "Science is the belief in the ignorance of the experts"

Mark Simon Managing Director, Torreya

2 / 4

I really enjoyed the meeting as usual - great topics and speakers. I look forward to next year's meeting!

Richard Brian Gaynor Sr. VP Global Development / Medical Affairs, Oncology Business Unit, Eli Lilly

3 / 4

Good array of opinions and technologies. Well curated.

Andrew Allen, MD, PhD President & CEO, Gritstone Oncology

4 / 4

Check out our latest Cancer Progress webinars & perspectives View all perspectives

On-Demand Webinar May 13, 2025

Immunotherapy’s Wild Ride: From Neglect to Stardom to Pariah – and Now Maybe Phoenix

View Jun 10, 2025

Back to the Future: Next Generation Platforms

On-Demand Webinar Nov 20, 2024

Upgrading ADCs to the Next Level: What Does the Future of Antibody Drug Conjugates Look Like?

On-Demand Webinar Oct 24, 2024

Adapting to Immuno-Oncology’s R&D Challenges: Refocusing on Innate Immunity as a “Next Big Thing” in Cancer Immunotherapy

On-Demand Webinar Jun 27, 2024

Cancer Progress: Oncology 2050: Have We Been Thinking About the Management of Cancer in the Right Way?

On-Demand Webinar Apr 30, 2024

Cancer Progress: What’s Next for IO: What and When Is the Next Game Changer?

View Past Live Cancer Progress Agendas